2026 Advanced Chemical & Biotech Patent Institute

If you plan on attending the Spring Meeting, there is special pricing for this event. You must register for the Spring Meeting at the same time.

If you only want to attend the 2026 Advanced Chemical Patent Practice Institute, select this event and click "Individual Registration".

_________________________________________________________________________________________________________________________

Thank you to our sponsors

Please email Lisa Beller if you are interested in sponsoring this event.

Speakers

• Anoff, Ali

  Procter & Gamble | Director & Assistant General Counsel - Patents

  Ali Anoff is Director and Assistant General Counsel at Procter & Gamble. She is the primary patent attorney for renowned brands such as Olay® skin care, as well as Old Spice®, Secret®, and Native® antiperspirant and deodorants. Ali provides strategic legal counsel to the business to create and protect global intellectual property assets. Her practice focuses on IP strategy development, preparation and prosecution of global patent applications, conducting freedom-to-practice assessments and enforcement.
• Barton, Matt

  Forresters | Partner

  Dr Matt Barton is a European and UK patent attorney and UPC Representative, and is Partner at Forresters where he heads the Munich office. Having qualified as a patent attorney in 2005, Matt is highly experienced in patent prosecution and drafting especially at the EPO and UKIPO. He has extensive experience of EPO opposition and appeal proceedings, handling multiple oral hearings each year, as well as freedom to operate and opinion work. His technical background is chemistry, with a focus on industrial chemistry, coating compositions, aerogels, battery materials, small molecules and drug conjugates. Matt’s particular specialism is in metallurgy, especially aluminium alloys and their methods of processing and production.
• Che, Jennifer

  Eagle IP | Managing Director

  Jennifer Che, J.D. is Managing Director at Eagle IP, a boutique patent firm headquartered in Greater China. Jennifer has a deep, multi-faceted understanding of cross-border (US-China) patent matters and the biopharmaceutical industry. Jennifer has the unique combination of close to 15 years' in-house IP experience in Boston (Vertex, Flagship-founded Axcella) together with 8 years being based in Asia and advising on China patent strategy. A recognized thought leader, frequent international speaker, and founder/author of the blog chinapatentstrategy.com, Jennifer guides international clients through complex China patent challenges and building strategic, global IP portfolios.
• Curcio, Stephanie

  NLPatent | CEO and Co-Founder

  Stephanie Curcio is a recognized leader at the intersection of artificial intelligence and patent law, with a focus on modernizing patent practice through workflow-aligned AI. She is the CEO and Co-Founder of NLPatent, where her work centers on applying proprietary AI models to support established patent research and intelligence workflows by automating high-friction tasks, surfacing conceptually relevant context, and reducing manual review - while preserving practitioner judgment, legal rigor, and explainability.
• Garberg, Morten

  Hoffmann Eitle | Partner

  Morten Garberg is a partner and co-head of HOFFMANN EITLE’s Chemistry and Pharmaceuticals practice group. Since starting his patent law career in the firm’s London office in 2002, Morten has gained extensive experience in representation of clients at the European Patent Office, specializing in opposition and appeal work. Now based in Munich, his expertise with patent work spans a wide variety of technical fields, including pharmaceuticals, polymers, foods and medical devices.
• Holloway, Chloe

  Hoffmann Eitle | British and European Patent Attorney, UPC Representative

  Chloe joined the Munich office of Hoffmann Eitle in 2016. Prior to joining Hoffmann Eitle, Chloe worked for a large Italian IP firm in Milan and for a boutique firm in Mexico City. Chloe works on drafting and prosecuting patent applications in a variety of different technical fields within chemistry, including organic chemistry, medicinal chemistry, pharmaceuticals and materials chemistry. She specialises in opposition and appeal proceedings before the EPO and has represented both patent proprietors and opponents in these proceedings.
• Irving, Thomas L.

  The Marbury Law Group, PLLC | Senior Partner

  Tom Irving is Senior Partner at the Marbury Law Group with some 50 years of experience in the field of intellectual property law. My practice emphasizes patent law experting, due diligence investigations, Orange Book listings, and counseling and opinion work, particularly on ODP and MPF. I successfully reissued the patent for the drug Lovenox®, a blockbuster product, and represented targets Agouron, Principia Biopharma, and Endocyte in patent work resulting in deals respectively garnering $2.1, $3.68, and $2.1 billion USD, as publicly reported. I filed an expert report and was cross examined on prosecution laches for CureVac against BioNTech /Pfizer. In settlement, CureVac received $740 million and a running royalty on Covid-19 vaccine sales in the U.S. I have also filed two expert reports dealing with inequitable conduct and one on duty of care in patent filing and prosecution. 
• Tostmann, Holger

  Casalonga | Partner

  With over 25 years of experience in European and US- patent prosecution, as well as extensive practice in opposition and appeal proceedings, where he has achieved well above-average success rates, Holger focuses on patents in the fields of pharma, polymers, materials science and batteries. He provides strategic advice on patent portfolio management, aligning deep technical expertise with legal experience to support clients’ commercial objectives.

• Outlook,
• ICal,
• Google Calendar